Skip to main content

Table 1 Patient characteristics and intensity and frequency of cough

From: Clinical significance of self-reported cough intensity and frequency in patients with interstitial lung disease: a cross-sectional study

Variable

IIPs (n = 70)

CTD-ILD (n = 49)

CHP (n = 10)

p-value

Age, years, mean ± SD

69.4 ± 8.9

66.5 ± 11.4

71.3 ± 7.5

0.185

Male sex, n (%)

56 (80)*

13 (27)

7 (70)

< 0.001

Current smoker, n (%)

9 (13)

1 (2)

0 (0)

0.082

Pack-years of smoking, median (IQR)

40 (16–52)

0 (0–15)†

16 (4–35)

< 0.001

Body mass indexa, mean ± SD

24.1 ± 3.3

23.1 ± 3.6

23.2 ± 2.0

0.279

FSSG score, median (IQR)

3 (1–7)

6 (2–12)†

4 (1–4)

0.010

MRC chronic dyspnoea scale, median (IQR)b

1 (1–2)

1 (1–2)

1 (1–3)

0.824

Pulmonary function tests, % predicted, median (IQR)c

 FEV1

82.9 (74.3–94.4)

94.2 (85.6–107.8)†

87.6 (78.8–90.1)

0.012

 FVC

85.2 (74.2–97.3)

93.6 (80.2–106.1)

73.6 (68.8–93.3)

0.090

 TLC

70.1 (64.3–85.8)

97.1 (79.8–104.1)†‡

68.5 (54.4–72.1)

< 0.001

 DLCO

49.2 (38.8–58.9)

55.2 (48.1–66.6)†

56.0 (37.2–62.9)

0.024

Composite Physiologic Index, median (IQR)c

43.2 (30.5–52.8)

34.8 (31.1–47.5)

43.5 (34.5–51.2)

0.157

Medication, n (%)

 Glucocorticoid

9 (13)*

30 (61)

4 (40)

< 0.001

 Antifibrotic agent

21 (30)*

0 (0)

2 (20)

< 0.001

 Proton pump inhibitor

21 (30)*

26 (53)

4 (40)

0.040

VAS score for cough, mm, median (IQR)

 Intensity

31 (17–55)§

24 (8–46)

18 (6–20)

0.048

 Frequency

24 (10–46)

13 (5–30)

10 (3–18)

0.060

Leicester Cough Questionnaire score, median (IQR)

 Physical

6.1 (5.5–6.4)

6.0 (5.0–6.5)

6.3 (6.0–6.6)

0.311

 Psychological

6.6 (5.9–7.0)

6.3 (5.3–7.0)

6.8 (6.1–7.0)

0.378

 Social

6.8 (6.0–7.0)

6.5 (5.3–7.0)

6.9 (6.0–7.0)

0.539

 Total

19.3 (17.5–20.4)

18.7 (15.4–20.5)

19.6 (18.3–20.6)

0.447

  1. The p-values are shown for across-group comparisons using one-way analysis of variance, the Kruskal-Wallis test, the chi-square test, or Fisher’s exact test as appropriate. Using a nominal 5% level of statistical significance, multiple comparisons were made using a Bonferroni-corrected significance level of 1.6% (p < 0.016). CHP, chronic hypersensitivity pneumonia; CTD-ILD, connective tissue disease-associated interstitial lung disease; DLco, diffusing capacity of the lung for carbon monoxide; FEV1, forced expiratory volume in 1 s; FSSG, frequency scale for symptoms of gastro-oesophageal reflux disease; FVC, forced vital capacity; IIPs, idiopathic interstitial pneumonias; IQR, interquartile range; MRC, Medical Research Council; SD, standard deviation; TLC, total lung capacity; VAS, visual analogue scale. aIIPs (n = 70), CTD-ILD (n = 49), CHP (n = 9); bIIPs (n = 69), CTD-ILD (n = 49), CHP (n = 10); cIIPs (n = 66), CTD-ILD (n = 48), CHP (n = 9). *p < 0.05 vs CTD-ILD or CHP; †p < 0.016 vs IIPs; ‡p < 0.016 vs CHP; §p = 0.067 vs CTD-ILD, p = 0.043 vs CHP